[
  {
    "ts": null,
    "headline": "Is Johnson & Johnson (JNJ) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?",
    "summary": "We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best pharma stocks to invest in now amid the domestic manufacturing boom. Trump Incentivizes Pharmaceuticals to Build Domestic Manufacturing […]",
    "url": "https://finnhub.io/api/news?id=d992f64c3a399cfc3eadaeb818a7b5c7e802f62670bfbb8ff10b16dbd9d76e45",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747170492,
      "headline": "Is Johnson & Johnson (JNJ) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?",
      "id": 134460754,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best pharma stocks to invest in now amid the domestic manufacturing boom. Trump Incentivizes Pharmaceuticals to Build Domestic Manufacturing […]",
      "url": "https://finnhub.io/api/news?id=d992f64c3a399cfc3eadaeb818a7b5c7e802f62670bfbb8ff10b16dbd9d76e45"
    }
  },
  {
    "ts": null,
    "headline": "Big Pharma Counted on This Loophole. It May Be Closing.",
    "summary": "Buried in a technical document released by the Centers for Medicare and Medicaid Services is a convoluted paragraph that may translate into big problems for Johnson & Johnson, Merck, and other drugmakers.",
    "url": "https://finnhub.io/api/news?id=bc3c2c07c3b20c416d36e745d9999a942a164e94ac62965ae8e33db9d122580d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747169580,
      "headline": "Big Pharma Counted on This Loophole. It May Be Closing.",
      "id": 134460755,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Buried in a technical document released by the Centers for Medicare and Medicaid Services is a convoluted paragraph that may translate into big problems for Johnson & Johnson, Merck, and other drugmakers.",
      "url": "https://finnhub.io/api/news?id=bc3c2c07c3b20c416d36e745d9999a942a164e94ac62965ae8e33db9d122580d"
    }
  },
  {
    "ts": null,
    "headline": "Big Pharma Counted On a Price Negotiation Loophole. It May Be Closing.",
    "summary": "Buried in a technical document released by the Centers for Medicare and Medicaid Services is a convoluted paragraph that may translate into big problems for Johnson & Johnson, Merck, and other drugmakers.",
    "url": "https://finnhub.io/api/news?id=0732a0a4ebfeaba42a3e496f478eed72f296bb9f58dfa773def09d730a3d3df0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747158900,
      "headline": "Big Pharma Counted On a Price Negotiation Loophole. It May Be Closing.",
      "id": 134408545,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Buried in a technical document released by the Centers for Medicare and Medicaid Services is a convoluted paragraph that may translate into big problems for Johnson & Johnson, Merck, and other drugmakers.",
      "url": "https://finnhub.io/api/news?id=0732a0a4ebfeaba42a3e496f478eed72f296bb9f58dfa773def09d730a3d3df0"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) BofA Securities 2025 Healthcare Conference Transcript",
    "summary": "Johnson &amp; Johnson (NYSE:JNJ) BofA Securities 2025 Healthcare Conference May 13, 2025 1:40 PM ETCompany ParticipantsJohn Reed - Executive Vice President,...",
    "url": "https://finnhub.io/api/news?id=3ab7ac2d44664eba1e30552c376252c392438ac4ffa3669aadd64000039b7697",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747147872,
      "headline": "Johnson & Johnson (JNJ) BofA Securities 2025 Healthcare Conference Transcript",
      "id": 134406465,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Johnson &amp; Johnson (NYSE:JNJ) BofA Securities 2025 Healthcare Conference May 13, 2025 1:40 PM ETCompany ParticipantsJohn Reed - Executive Vice President,...",
      "url": "https://finnhub.io/api/news?id=3ab7ac2d44664eba1e30552c376252c392438ac4ffa3669aadd64000039b7697"
    }
  },
  {
    "ts": null,
    "headline": "Top Biotech Halozyme Undercuts Its Breakout On Bad Medicare News",
    "summary": "Halozyme Therapeutics shares tumbled Tuesday on a new Medicare approach to price negotiations for drugs that use additive products.",
    "url": "https://finnhub.io/api/news?id=f147396558cb3b63b8758c61c9ddb73e2f08f172b77971c94e101f005a4cd0ce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747145994,
      "headline": "Top Biotech Halozyme Undercuts Its Breakout On Bad Medicare News",
      "id": 134408547,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Halozyme Therapeutics shares tumbled Tuesday on a new Medicare approach to price negotiations for drugs that use additive products.",
      "url": "https://finnhub.io/api/news?id=f147396558cb3b63b8758c61c9ddb73e2f08f172b77971c94e101f005a4cd0ce"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer, Eli Lilly, and Other Pharma Stocks Fall. Questions Remain About Trump’s Executive Order.",
    "summary": "Pfizer, Eli Lilly, and Other Pharma Stocks Fall. Questions Remain About Trump’s Executive Order.",
    "url": "https://finnhub.io/api/news?id=739d3ed17a603762852946b34da9dfc7b1a039ebb1f0c50bb8bc5f5a5f47e20e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747135080,
      "headline": "Pfizer, Eli Lilly, and Other Pharma Stocks Fall. Questions Remain About Trump’s Executive Order.",
      "id": 134401894,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Pfizer, Eli Lilly, and Other Pharma Stocks Fall. Questions Remain About Trump’s Executive Order.",
      "url": "https://finnhub.io/api/news?id=739d3ed17a603762852946b34da9dfc7b1a039ebb1f0c50bb8bc5f5a5f47e20e"
    }
  },
  {
    "ts": null,
    "headline": "Dow's 150-point fall led by losses for UnitedHealth, Merck stocks",
    "summary": "Dow's 150-point fall led by losses for UnitedHealth, Merck stocks",
    "url": "https://finnhub.io/api/news?id=62c04e7ffe917c2a19078127aff197dbe8830b6dd6f1239e053ec28ff2ea138d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747129500,
      "headline": "Dow's 150-point fall led by losses for UnitedHealth, Merck stocks",
      "id": 134402141,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Dow's 150-point fall led by losses for UnitedHealth, Merck stocks",
      "url": "https://finnhub.io/api/news?id=62c04e7ffe917c2a19078127aff197dbe8830b6dd6f1239e053ec28ff2ea138d"
    }
  },
  {
    "ts": null,
    "headline": "With the breakneck speed of cancer breakthroughs, oncologists feel left behind. Can Big Pharma chime in?",
    "summary": "Community oncologists do their best to keep up with new treatments, but with the pace of cancer approvals, drugmakers need to team up with doctors on the front line.",
    "url": "https://finnhub.io/api/news?id=07e6a9bd2020eeda699e228d06322605030c53e2107224ae807ee1a6c805b5fc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747123200,
      "headline": "With the breakneck speed of cancer breakthroughs, oncologists feel left behind. Can Big Pharma chime in?",
      "id": 134408549,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Community oncologists do their best to keep up with new treatments, but with the pace of cancer approvals, drugmakers need to team up with doctors on the front line.",
      "url": "https://finnhub.io/api/news?id=07e6a9bd2020eeda699e228d06322605030c53e2107224ae807ee1a6c805b5fc"
    }
  },
  {
    "ts": null,
    "headline": "Vietnam cranks up fight on imported counterfeits amid US tariff talks",
    "summary": "Vietnam is stepping up itsfight against counterfeits and digital piracy after the UnitedStates accused the country of being a major hub for theseillegal activities and threatened crippling tariffs,...",
    "url": "https://finnhub.io/api/news?id=94eca253a865e09c22fa237c8aed6fb4044d460771f2fa205e9c905dad8c126a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747098949,
      "headline": "Vietnam cranks up fight on imported counterfeits amid US tariff talks",
      "id": 134395053,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Vietnam is stepping up itsfight against counterfeits and digital piracy after the UnitedStates accused the country of being a major hub for theseillegal activities and threatened crippling tariffs,...",
      "url": "https://finnhub.io/api/news?id=94eca253a865e09c22fa237c8aed6fb4044d460771f2fa205e9c905dad8c126a"
    }
  }
]